Literature DB >> 32586921

Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.

Zoé Gendebien1, Christian von Frenckell1, Clio Ribbens1, Béatrice André1, Marie Thys2, Marjorie Gangolf2, Laurence Seidel2, Michel G Malaise1, Olivier Malaise3.   

Abstract

Entities:  

Keywords:  glucocorticoids; hydroxychloroquine; lupus erythematosus, systemic

Mesh：

Substances：

Year:  2020        PMID： 32586921     DOI： 10.1136/annrheumdis-2020-218244

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

2.  COVID-19, rheumatic diseases and immune dysregulation-a perspective.

Authors:  Shahna Tariq; Charmaine Van Eeden; Jan Willem Cohen Tervaert; Mohammed S Osman
Journal:  Clin Rheumatol       Date:  2021-01-07       Impact factor: 2.980

Review 3.  SARS-CoV-2 and Systemic Lupus Erythematosus.

Authors:  Aikaterini Thanou; Amr H Sawalha
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

Review 4.  COVID-19 illness and autoimmune diseases: recent insights.

Authors:  Juan Li; Hong-Hui Liu; Xiao-Dong Yin; Cheng-Cheng Li; Jing Wang
Journal:  Inflamm Res       Date:  2021-02-28       Impact factor: 4.575

Review 5.  COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.

Authors:  Ruth Fernandez-Ruiz; Jacqueline L Paredes; Timothy B Niewold
Journal:  Transl Res       Date:  2020-12-19       Impact factor: 7.012

6.  COVID-19 in patients with systemic lupus erythematosus: A systematic review.

Authors:  Xue-Lei Fu; Yan Qian; Xiao-Hong Jin; Hai-Rong Yu; Lin Du; Hua Wu; Hong-Lin Chen; Ya-Qin Shi
Journal:  Lupus       Date:  2022-04-05       Impact factor: 2.858

7.  Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.

Authors:  Ji-Won Kim; Sang Gyu Kwak; Hwajeong Lee; Seong-Kyu Kim; Jung-Yoon Choe; Sung-Hoon Park
Journal:  Korean J Intern Med       Date:  2021-03-12       Impact factor: 3.165

8.  Humoral and cellular response in convalescent COVID-19 lupus patients.

Authors:  Cristina Solé; Sandra Domingo; Xavier Vidal; Josefina Cortés-Hernández
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

Review 9.  COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.

Authors:  Renuka Raman; Krishna J Patel; Kishu Ranjan
Journal:  Biomolecules       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.